← Back to All Filings

Medtronic Inc. Senior Notes Delisted from NYSE After Maturity

Low SignificanceOctober 15, 2025 at 10:04:28 AM EDT

MEDTRONIC INC

25-NSECIK: 0000064670

Filing Summary

Medtronic Inc. Senior Notes Delisted from NYSE After Maturity

Company: MEDTRONIC INC (CIK: 0000064670) Form: 25-NSE | Filed: 2025-10-15 Significance: Low

Event Details: • Action: Removal from Listing • Security: Guarantor of 0.000% Senior Notes due 2025 • Reason: The security was redeemed and paid at maturity on 2025-10-15.

Key Insight: This is a routine administrative filing by the NYSE to delist a specific Medtronic debt security that has reached its maturity date.

Market Context: This action is a standard procedure for maturing bonds and has no direct impact on Medtronic's common stock or its financial health.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: MEDTRONIC INC

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: This Form 25-NSE filing is a notification from the New York Stock Exchange (NYSE) about the routine delisting of a specific Medtronic debt security (Senior Notes) because it has reached its maturity date and been fully redeemed.
  • Market Impact: Neutral. This is a scheduled administrative event and is not expected to have any impact on Medtronic's common stock or overall market sentiment towards the company.

Company Information

FieldValue
CompanyMEDTRONIC INC
Ticker SymbolNot specified in filing
CIK0000064670
IndustryElectromedical & Electrotherapeutic Apparatus [3845]

Insider Information

FieldValue
NameNot Applicable
CIKNot Applicable
Title/PositionNot Applicable
RelationshipNot Applicable

Delisting Details

FieldValue
Form Type25-NSE
Event Date2025-10-15
Filing PartyNEW YORK STOCK EXCHANGE LLC
Security TypeGuarantor of 0.000% Senior Notes due 2025
Reason for DelistingRedeemed or paid at maturity or retirement.
Exchange Rule17 CFR 240.12d2-2(a)(2)

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The delisting pertains to a debt instrument that has reached the end of its lifecycle as planned. This is a normal course of business for a company managing its debt portfolio and carries no new information about the company's operational performance or financial stability. Equity investors should not view this as a significant event.

Volume & Sentiment

  • Expected Volume Impact: None. Trading for this specific security was suspended on October 15, 2025, as it no longer exists post-redemption. There will be no impact on the trading volume of Medtronic's common stock.
  • Sentiment Indicator: Neutral. The filing confirms the company met its debt obligation, which is a standard financial activity, not a bullish or bearish signal.

Investment Insights

Positive Market Indicators

  • The filing confirms that Medtronic has successfully met its debt obligations by redeeming the notes at maturity, demonstrating financial solvency.

Risk Factors

  • This filing does not present any new risk factors.

Key Takeaways

  1. Routine Administrative Action: The Form 25-NSE is a procedural notification from the NYSE and not an action initiated by Medtronic due to distress or negative circumstances.
  2. Debt Maturity: The core event is the successful redemption of a series of senior notes, which is a standard part of corporate finance.
  3. No Equity Impact: This event is isolated to a specific debt security and has no bearing on the value, listing, or trading of Medtronic's common stock.

Contextual Analysis

Timing Significance

  • The filing date of October 15, 2025, coincides exactly with the date of redemption and suspension of trading for the security, as stated in the document. The timing is purely administrative.

Transaction Context

  • The context is the lifecycle of a debt instrument. The notes were issued, served their term, and were paid back at maturity. The delisting is the final step in this process.

Company Context

  • For a large-cap company like Medtronic, issuing and retiring debt is a continuous and normal part of its treasury and capital management strategy. This event is business as usual.

Risk Assessment

Risk Level: Low

Risk Factors

  • This filing itself introduces no new risks to investors. It is a confirmation that a financial obligation has been met.

Market Considerations

  • Investors should differentiate between a delisting due to maturity (as in this case) and a delisting due to non-compliance with exchange rules, which would be a significant negative event.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-15 | Data source: SEC EDGAR

Topics:#SECFiling#Medtronic#NYSE#Delisting#CorporateAction#DebtSecurity#Form25NSE#Finance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.